Retro biosciences stock price

This means our website may not look and work as you would expect.

Bloomberg -- Sam Altman became the face of the artificial intelligence craze through his role as chief executive officer of OpenAI. But his wealth goes far beyond the startup behind ChatGPT. Altman has repeatedly said that he does not own equity in the company. Altman became a globe-trotting AI evangelist, using his pulpit to both inspire and terrify with his predictions about what the technology augurs for elections, art, education, economies and society. Elon Musk, a co-founder of OpenAI, sued Altman and the startup Thursday for violating its founding mission by prioritizing profit over benefiting humanity. Regulators are now studying his internal messages as part of a probe into whether investors were misled, the Wall Street Journal reported Thursday. The sources of his wealth are relatively opaque.

Retro biosciences stock price

Private longevity research companies deserve investor attention as the longevity side of the life science market grows. Longevity research companies are working to promote healthy aging and extend life expectancy. A long, healthy life is something everyone has a vested interest in, but that doesn't mean it's always easy to get into longevity investing. Many longevity research companies remain private, meaning it's difficult for the average person to secure a stake. However, investors shouldn't ignore private longevity research companies. They represent a potential opportunity to gain exposure to rapid growth in a sector that touches diverse life science markets. Plenty of private longevity research companies are working on innovative studies aimed at diseases associated with aging, including cardiovascular disease, type 2 diabetes and various cancers. If they do go public one day, investors who have them on their radar already will be ahead of the game. Here's a short list of some of the top private longevity research companies making headlines today. Altos Labs Based in Los Altos, California, Altos Labs is a biotechnology company that is developing cellular rejuvenation programming to promote healthy cells in the human body and revive cells damaged by environmental stresses.

Now at Retro, Andrei applies his broad expertise to advance aging modeling using computational methods, AI, and machine learning. Jared joined the computational biology team at Retro to work on understanding ageing retro biosciences stock price reprogramming with single-cell -omics and machine learning. In Spain, he was bip wordlist private practice and consulted as a Swine Reproduction veterinarian.

He was part of a three-person team at Caltech that first elucidated the factors governing electron-tunneling rates in proteins, which is published in journals such as Science and JACS , with over citations so far. His second startup, Vium, automated animal research to accelerate medical research. Joe spent 2. Joe is presently CEO of his third venture-funded startup, Retro Biosciences, which is creating therapeutics against targets elucidated by its research in aging biology, with the mission of increasing healthy human lifespan by ten years. Matt Buckley completed his PhD in the aging research lab of Dr. Anne Brunet at Stanford prior to co-founding Retro.

From Jeff Bezos to Jack Dorsey, billionaires are using their wealth to fight aging. From billionaires like Peter Thiel to Jeff Bezos , a seemingly growing number of billionaires is funneling cash into longevity research, or science that can potentially offer solutions to extend lifespans. According to the report, Altman's is the sole backer of the startup, which came out of stealth in April. Altman didn't respond to a request for comment and Retro declined to comment. Retro says its mission "is to add 10 years to a healthy human lifespan. Altman told MIT Technology Review that he thinks of the companies he's involved in today as "hard" startups, or companies that need lots of cash in order to pursue expensive and difficult technologies and ideas. Like, scale it up and see what happens," he told the publication.

Retro biosciences stock price

Thanks for contacting us. We've received your submission. Altman — the recently-reinstated CEO of ChatGPT-maker OpenAI — reportedly mulled funding a smaller longevity-technology-focused company around a single therapy that followed the more traditional route of chasing a singular breakthrough that one day heads into clinical trials and sell its results to a pharmaceutical or medical device giant. Since that investment two years ago, Retro has primarily operated in secrecy, opening its office and laboratories for perusal for the first time to Bloomberg this month.

New orleans pelicans vs cleveland cavaliers matches

Please refer to the cookie policy for collected data, privacy and GDPR compliance. Learn about our editorial policies. His work has been published in Elife and Nature Biotechnology. Tobias has authored numerous articles in top-tier journals and his work has been cited over times. Jake Halady. It had set up its headquarters in a raw warehouse space near San Francisco just the year before, bolting shipping containers to the concrete floor to quickly make lab space for the scientists who had been enticed to join the company. Now they combine their background to develop low cost single cell multi-omic technologies and adapt assays for large scale automation. Jessica Dickerson Research Operations Manager. Skip to main content. As an Eagle Scout, Arjun loves being outdoors, and you can find him hiking or occasionally scuba diving on the weekends. Throughout her time in Silicon Valley, she has worked for numerous companies specializing in technology hardware, software development, and biomedical innovation.

Another mysterious longevity company has come out of stealth with the backing of hundreds of millions of dollars. If you are wondering who the investors are that have put up this large round of funding, get in line. For right now, the company is staying tight lipped on exactly where the money is from.

The company took a type of machine-learning program called a transformer and steadily scaled it up, spending more than a billion dollars to buy computer time as it built its products. Biotechnology and health. Raul Garcia-Gonzalez. Full Bio Follow. But his wealth goes far beyond the startup behind ChatGPT. The three programs will focus on cellular reprogramming, autophagy and plasma-inspired therapeutics. He brings a unique wealth of legal, pharma, management and leadership experiences. Try one of these. Joseph Fraietta. Prior to joining, he acquired 4 years of experience in Accounts Payable, two of which were in the biotech industry Iovance Biotherapeutics and ArsenalBio. Tobias has extensive research experience across various fields, including biomarker research, tool and algorithm development, and atlas-based research. Sruthi has always been curious and driven to define and solve problems at the intersection of engineering and biology.